1Hussain,S.P.et al.Inflammation and cancer:an ancient link with novel potentials.Int.J.Cancer 2007,121,2373-2380.
2Mantovani,A.et al.Tumour immunity:effector response to tumour and role of the microenvironment.Lancet 2008,371,771-783.Greten,F.R.et al.
3IKKbeta links inflammation and tumorigenesis in a mouse model of colitis -associated cancer.Cell 2004,118,285-296.
4Hussain SP,Harris CC.Inflammation and cancer:an ancient link with novel potentials.Int J Cancer 2007; 121:2373 -80.
5Wu WS.The signaling mechanism of ROS in tumor progression.Cancer Metastasis Rev 2006; 25:695-705.
6Azad N,Rojanasakul Y,Vallyathan V.Inflammation and lung cancer:roles of reactive oxygen/nitrogen species.J Toxicol Environ Health B Crit Rev 2008;11:1-15.
7Hussain SP,Amstad P,Raja K,Ambs S,Nagashima M,Bennett WP,et al.Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis:a cancer-prone chronic inflammatory disease.Cancer Res 2000; 60:3333 -7.
8Shahrzad S,Bertrand K,Minhas K,Coomber BL.Induction of DNA hypomethylation by tumor hypoxia.Epigenetics 2007; 2:119 -25.
9LimSO,GuJM,KimMS,KimHS,Park YN,ParkCK,et al.Epigeneticchanges induced by reactive oxygen species in hepatocellular carcinoma:methylationof the E-cadherin promoter.Gastroenterology 2008; 135:2128-40.
10Baron,J.A.et al.A randomized trial of aspirin to prevent colorectal adenomas.N.Engl.J.Med.2003,348,891-899.
二级参考文献18
1Zlotnik A , Yoshie O. Chemokines: a new classification system and their role in immunity [Jl. Immunity, 2000, 12(2) : 121-127.
2Cambell J J, Butcher EC. Chemokines in tissue-specific and rnicroenvironrnent-specific lyrnphoeyte homing [J]. Curr Opin Immunol, 2000, 12 (3):336-341.
3Butcher EC, Williams M, Youngman K, et al. Lymphocyte trafficking and regional immunity [J]. Adv Immunol, 1999, 72 : 209-253.
4Nagasawa T, Hirota S, Tachibana K, et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1 [J]. Nature, 1996, 382 (6592) : 635-638.
5Tachibana K, Hirota S, Iizasa H, et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract [J]. Nature, 1998, 393 (6685) :591 -594.
6Peled A, Grabovsky V, Habler L, et al. The chemokine SDF-1 stimulates integrin-mediated arrest of CD34 + cells on vascular endothelium under shear flow [J]. J Clin Investig, 1999, 104(9) : 1199-1211.
7Feil C, Augustin HG. Endothelial cells differentially express functional CXCR4-chemokine receptor-4 (CXCR-4/fusin) under the control of autocrine activity and exogenous cytokines [J]. Biochem Biophys Res Commun, 1998, 247(5):46-53.
8Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis [J]. Nature, 2001, 410(1):50-56.
9Koshiba T, Hosotani R, Miyamoto Y, et al. Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role of tumor progression [J]. Clin Cancer Res, 2000, 6(9):3530-3535.
10Butcher EC, Williams M, Youngman K, et al. Lymphocyte trafficking and regional immunity [J]. Adv Immunol, 1999,72: 209-253.
6Xu T, Xu RA. Progress on ati - tumor mechanism of Chinese medicine and its active ingredients [ J] . Journal of Huaqiao University (Natural Science), 2009, 30 (4): 359-365.
7Reinartz S, Schumann T, Finkernagel F, et al. Mixed- polariza- tion phenotype of ascites - associated macrophages in human ovari- an carcinoma: correlation of CD163 expression, cytokine levels and early relapse [J] . Int J Cancer, 2014, 134 (1) : 32 -42.
8Pourgholami MH, Ataie - Kachoie P, Badar S, et al. Minocy- eline inhibits malignant ascites of ovarian cancer through targeting multiple signaling pathways [ J] . Gynecol Oncol, 2013, 129 (1): 113-119.
9Hung A Y,Futai K,Sala C,et al.Smaller dendritic spines,weaker synaptic transmission,but enhanced spatial learning in mice lacking Shankl[J].JNeuroscit 2008,28(7):1697-1708.
10Huett A,Leong J M,Podolsky D K,et al.The cytoskeletal scaffold Shank3 is recruited to pathogen-induced actin rearrangements[J].Exp Cell Res,2009,315(12):2001-2011.
